Begin typing your search...

    In bullish market, net FII inflow crosses Rs 14,000 cr in 3 days

    The Indian equity market has been on a fresh record run of late backed by a surge in foreign institutional investments (FII). In the past three days alone, net FII inflow in the Indian capital markets stood at Rs 14,786.57 crore.

    In bullish market, net FII inflow crosses Rs 14,000 cr in 3 days
    X

    Mumbai

     On Tuesday, the Sensex crossed the psychological mark of 43,000 points for the first time ever. The surge in the Indian market comes in line with the global markets, after pharmaceutical major Pfizer said its experimental COVID-19 vaccine is more than 90 per cent effective based on initial trial results.

     Further, the bull-run started globally along with the domestic markets after it became clear that Joe Biden, the Democratic candidate would be the next US President. This positive trend comes despite the anticipation that Donald Trump’s exit from the White House may trigger a collapse in the stocks markets.

     Markets rallied on hopes of fewer regulations, easing of protectionist measures brought in by Trump and a bigger stimulus package for the US economy under a Biden administration. Further, hopes of ease in H-1B visa norms led to a spike in IT stocks. 

    FIIs have been the biggest push for the recent bull-run in the Indian markets. Post the significant outflow in September, foreign funds made a comeback in October and the flow has strengthened further in November.

     FII inflows in October stood at $2.5 billion. However, at a time when FIIs have been net buyers, domestic institutional investments (DII) have remained net sellers. In October, DII outflow stood at $2.4 billion, highest monthly outflows since March 2016.

     So far in November, net DII outflow stands at Rs 9,826.17 crore, while net FII inflow stands at Rs 17,947.80 crore.

    Pfizer shares up 20 pc post-vaccine report
    Shares of Pfizer zoomed nearly 20 per cent on Tuesday after Pfizer Inc and BioNTech SE said their vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19. The stock jumped 16.29 per cent to Rs 5,875 – its record high – on the BSE. At the NSE, it gained 19.83 per cent to its lifetime high of Rs 5,900.

    Visit news.dtnext.in to explore our interactive epaper!

    Download the DT Next app for more exciting features!

    Click here for iOS

    Click here for Android

    migrator
    Next Story